Press releases

M*Modal Selected by TransTech Medical Solutions for Best-in-Class Clinical Documentation

Published on June 27, 2012

Medical Solutions Provider Offers M*Modal Fluency for Transcription™ to Healthcare Customers

Franklin, TN – TBD – M*Modal (NASDAQ/GS: MODL), a leading provider of clinical documentation services and Speech Understanding solutions, today announced TransTech Medical Solutions has selected M*Modal Fluency for Transcription™ to deliver advanced medical transcription solutions to its hospital and healthcare customers. As part of the agreement, TransTech, ranked #1 in the 2011 Best in KLAS year-end report, will roll out M*Modal Fluency for Transcription’s cloud-based transcription services to all of its new clients.

“We are proud to be selected by TransTech to deliver industry-leading quality transcription services to its growing base of healthcare clients,” said Vern Davenport, chairman and CEO, M*Modal. “Our leading cloud-based technology combined with TransTech’s reputation for providing best-in-class service exemplifies our shared focus and determination to bring healthcare organizations the best and latest technology solutions.”

Announced in May, M*Modal Fluency for Transcription™ is a cloud-based solution for dictation capture, speech recognition editing, electronic signature, and document distribution to optimize clinical information workflow, speed up the revenue cycle, help achieve HIPAA and regulatory compliance, as well as help meet Meaningful Use and electronic health record requirements.

“About a year ago we began exploring new clinical documentation platforms so that we could offer a complete solution to our hospital and healthcare clients. Having had a lot of experience in the speech recognition space, we were very familiar with M*Modal’s impressive work in this space and were excited to learn about the Fluency family of clinical solutions,” said Sidney (Trey) Weiss, CEO, TransTech.

“In our evaluation of M*Modal Fluency for Transcription™ we found it incomparable to secondary technologies on-market, from its scalability, uptime and the quality of the documentation to the opportunities it affords our customers in maximizing their own productivity. M*Modal Fluency for Transcription™ is unmatched by other industry offerings and we are excited to make it available to some of the country’s largest and most prestigious healthcare organizations,” said Tracy Boesch, president and COO, TransTech.

For more information on M*Modal please visit or follow on Twitter @MModal.

About TransTech
TransTech Medical Solutions is a 100% domestic provider of medical transcription and healthcare documentation services, providing clients with innovative, advanced and customizable solutions. The Company’s client base includes some of the nation’s largest and most prestigious healthcare institutions. For more information, visit

About M*Modal
M*Modal (NASDAQ/GS: MODL) is a leading provider of clinical transcription services, clinical documentation workflow solutions, advanced cloud-based Speech UnderstandingTM technology, and advanced unstructured data analytics. Recognized as the largest clinical transcription service in the U.S. with a global network of medical editors, M*Modal also offers voice to text solutions to capture the complete patient story, codifies the doctor’s narrative to automatically populate EHRs and other key healthcare information systems, delivers computer-assisted coding to support ICD-9 and the transition to ICD-10, and provides highly advanced analytical tools for exploring the richness within the “unstructured” narrative for improvements in quality of care, greater physician satisfaction and lower operational costs. For more information, please visit, Twitter, Facebook and YouTube.

Forward-Looking Statements
Information provided and statements contained in this press release that are not purely historical, such as statements regarding our expectations regarding our future business plans are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. Such forward-looking statements only speak as of the date of this press release and the Company assumes no obligation to update the information included in this press release. Statements made in this press release that are forward-looking in nature may involve risks and uncertainties. Accordingly, readers are cautioned that any such forward-looking statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict, including, without limitation, specific factors discussed herein and in other releases and public filings made by the Company (including filings by the Company with the Securities and Exchange Commission). Although the Company believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. Unless otherwise required by law, the Company also disclaims any obligation to update its view of any such risks or uncertainties or to announce publicly the result of any revisions to the forward-looking statements made in this press release.

Media Contacts:
Joe McNamara
(267) 535-6833

Amanda Guisbond
SHIFT Communications
(617) 779.1813

Investor Contacts:
Ron Scarboro
(615) 798-4350

Tripp Sullivan
Corporate Communications, Inc.
(615) 324-7335